Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 156 (1) , 31-36
- https://doi.org/10.1016/j.cancergencyto.2004.04.004
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- Quantitative Gstp1 Methylation Clearly Distinguishes Benign Prostatic Tissue And Limited Prostate AdenocarcinomaJournal of Urology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- The polycomb group protein EZH2 is involved in progression of prostate cancerNature, 2002
- Cytogenetics and molecular genetics of cancer of the prostateAmerican Journal of Medical Genetics, 2002
- DNA methylation in cancer: too much, but also too littleOncogene, 2002
- DNA hypermethylation in tumorigenesis: epigenetics joins geneticsTrends in Genetics, 2000
- Cancer-epigenetics comes of ageNature Genetics, 1999
- Epigenetic Mechanisms for Progression of Prostate CancerCancer and Metastasis Reviews, 1998
- The 5-methylcytosine content of DNA from human tumorsNucleic Acids Research, 1983